Skip to main content
Clinical Trials/JPRN-UMIN000001305
JPRN-UMIN000001305Completed未知

Beneficial effects of cholesterol absorption inhibitor,ezetimibe on impaired endothelial function in patients with metabolic syndrome. - EZET-trial

Tohoku University Graduate School of Medicine EZET-trial group0 sites60 target enrollmentStarted: September 12, 2008Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) History of drug hypersensitivity to ezetimibe. 2) History of chronic heart failure. 3) Patients who have insulin therapy. 4) Patients who have severe liver dysfunction. Patients who have severe kidney dysfunction. 5) Patients who have secondary dyslipidemia or drug-induced dyslipidemia. 6) Pregnant or possibly pregnant patients. 7) Other patients deemed unsuitable as subjects of the study by the treating physician.

Investigators

Sponsor
Tohoku University Graduate School of Medicine EZET-trial group

Similar Trials

Beneficial effects of cholesterol... | Clinical Trial